Masuyer, G., Beard, M., Cadd, VA, Chaddock, JA & Acharya, KA. Structure and activity of a functional derivative of Clostridium botulinum neurotoxin B. J.
Structural Biology 2011, 174, 52-57
Masuyer, G, Thiyagarajan, N., James, P.L., Marks, P.M.H., Chaddock, J.A. & Acharya, K.R. Crystal structure of a catalytically active, non-toxic endopeptidase derivative of Clostridium botulinum toxin A.
Biochem Biophys Res Commun (2009) 381: 50-53
Fdez, E., Jowitt, T.A., Wang, M.-C., Rajebhosale, M., Foster, K., Bella, J., Baldock, C., Woodman, P.G. & Hilfiker, S. A role for N-Ethylmaleimide-sensitive factor attachment protein receptor complex dimerization during neurosecretion.
Mol. Biol Cell (2008) 19: 3379-89
Sutton, J.M., Wayne, J., Scott-Tucker, A., O’Brien, S.M., Marks, P.M.H., Alexander, F.C.G., Shone, C.C. and Chaddock, J.A. Preparation of specifically activatable endopeptidase derivatives of Clostridium botulinum toxins type A, B and C and their applications.
Protein Expression & Purification 2005, 40(1), 31-41.
Chaddock, J.A., Duggan, M.J., Quinn, C.P., Purkiss, J.R., Alexander, F.C.G., Doward, S., Fooks, S.J., Friis, L., Hall, Y., Kirby, E.R., Leeds, N.J., Moulsdale, H.J., Dickenson, A., Green, G.M., Rahman, W., Suzuki, Rie, Shone, C.C. and Foster, K.A. Retargeted clostridial endopeptidases: Inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain.
Movement Disorders 2004, 19(S8), S42-S47.
Duggan, M.J., Quinn, C.P., Chaddock, J.A., Purkiss, J.R., Alexander, F.C.G., Doward, S., Fooks, S.J., Friis, L., Hall, Y., Kirby, E.R., Leeds, N.J., Moulsdale, H.J., Dickenson, A., Green, G.M., Rahman, W., Suzuki, Rie, Shone, C.C. and Foster, K.A. Inhibition of release of neurotransmitters from rat dorsal root ganglia by a novel conjugate of a Clostridium botulinum toxin A endopeptidase fragment and Erythrina cristagalli lectin.
J. Biol. Chem. 2002, 277(38), 34846-34852.
Chaddock, J.A., Herbert, M.H., Ling, R., Alexander, F.C.G., Fooks, S.J., Revell, D., Quinn, C.P., Shone, C.C. & Foster, K.A. Expression and purification of catalytically active, non-toxic derivatives of Clostridium botulinum toxin type A.
Protein Expression Purification 2002, 25, 219-228.
Foster, K.A. Novel Toxin Developments: Delivery of Endopeptidase Activity of Botulinum Neurotoxin to New Target Cells.
Scientific and Therapeutic Aspects of Botulinum Toxin, Chapter 48, eds. Brin, MF., Jankovic, J. & Hallett, M., Lippincott Williams & Wilkins, Philadelphia, 2002.
Chaddock, J.A., Purkiss, J.R., Duggan, M.J., Quinn, C.P., Shone, C.C. & Foster, K.A. A conjugate composed of nerve growth factor coupled to a non-toxic derivative of Clostridium botulinum neurotoxin type A can inhibit neurotransmitter release in vitro.
Growth Factors 2000, 18(2), 147-155.
Chaddock, J.A., Purkiss, J.R., Friis, L.M., Broadbridge, J.D., Duggan, M.J., Fooks, S.J., Shone, C.C., Quinn, C.P. & Foster, K.A. Inhibition of vesicular secretion in both neuronal and non-neuronal cells by a retargeted endopeptidase derivative of Clostridium botulinum neurotoxin type A.
Infection & Immunity 2000, 68: 2587-2593.